If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
475.00    2.50 (0.53%)
Bid:
470.00
Ask:
480.00
Spread: 10.00 (2.128%)
Market Cap: £83.96m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Proposed transfer to AIM

2 Feb 2005 07:00

Embargoed Release: 02 February 2005 0700hrs Toad Group plc ("the Company") Proposed transfer to AIM and exercise of option to acquire the remaining preference shares in 21st Century Toad Group plc announced today that it is planning to move the Company'sordinary shares from the Official List of the United Kingdom Listing Authority(the "Official List") to the Alternative Investment Market of the London StockExchange ("AIM") in the second quarter of 2005.The transfer to AIM will allow the Company to pursue acquisitions in the mostcost effective manner and will simplify the ongoing administration andreporting requirements of the company.In view of the encouraging early progress made with its recent 25% investmentin 21st Century Crime Prevention Services Limited ("21st Century") thedirectors are keen to exercise the Company's option to acquire a further 24% of21st Century at the option price of ‚£750,000 in cash. These remainingpreference shares yield a dividend entitlement of ‚£245,000 per annum which willbring the cumulative dividend entitlement to ‚£500,000 per annum. The directorsintend to exercise this option only once the Company has moved across to AIM toavoid the disproportionate costs which would otherwise be associated with thetransaction if the Company were to remain on the Official List. The Company hasa further option to acquire the remaining 51% of 21st Century.As an AIM company, the Company will continue to be subject to the regulatoryand disciplinary controls of the London Stock Exchange. The board believes thatAIM, with its lower cost of complying with continuing obligations, is a moreappropriate market for the Company given its size and shareholder base.Shareholders should be reassured that, so far as is known to the directors,with the exception of shares held in a Personal Equity Plan or an IndividualSavings Account, the transfer to AIM will in no way affect their ability tohold shares in the Company and existing share certificates will remain valid.Shareholders should note that shares held in companies trading on AIM aretreated as unquoted for purposes of certain tax reliefs, although shareholdersshould seek their own financial advice on this point.The group is currently trading in line with market expectations and expects torelease its Year End Figures in the middle of March 2005. -ENDS- For enquiries please contact:Peter WardChairman, Toad Group plcWilson JenningsFinance Director, Toad Group plcTel: 020 8710 4000Ben SimonsHansard CommunicationsTel: 020 7245 1100END
Date   Source Headline
17th Dec 20241:13 pmRNSHolding(s) in Company
17th Dec 20247:00 amRNSContract Extension
9th Dec 202410:36 amRNSHolding(s) in Company
4th Dec 20241:34 pmRNSHolding(s) in Company
25th Nov 20247:00 amRNSPurchase Orders
15th Oct 20245:37 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSEstablishment of Long-Term Incentive Plan
17th Sep 20247:00 amRNSInterim Results
30th Jul 20247:00 amRNSTrading Update
29th Jul 20247:00 amRNSPurchase Order
16th Jul 20247:00 amRNSContract Awards
27th Jun 20241:17 pmRNSHolding(s) in Company
5th Jun 20244:03 pmRNSDirector/PDMR Shareholding
29th May 20245:25 pmRNSHolding(s) in Company
25th Apr 202411:40 amRNSDirector/PDMR Shareholding
25th Apr 20249:07 amRNSResult of AGM
22nd Apr 20247:00 amRNSService and support contract in Sweden
28th Mar 20247:00 amRNSPurchase Order
27th Mar 202410:33 amRNSDirector Share Purchases
26th Mar 20247:00 amRNSPurchase Orders
26th Mar 20247:00 amRNSFinal Results
21st Mar 20247:00 amRNSNotice of Results
11th Mar 20247:00 amRNSPurchase Orders
21st Feb 202410:52 amRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNS£5 million Framework Agreement
29th Jan 20244:54 pmRNSHolding(s) in Company
22nd Jan 20245:34 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 202411:46 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20237:01 amRNSMello Conference
28th Nov 20237:00 amRNSTrading Update
10th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 20237:00 amRNSChange of Nominated Adviser and Broker
11th Oct 20239:43 amRNSIssue of Equity
9th Oct 202310:27 amRNSIssue of Equity & PDMR Dealing
28th Sep 20237:00 amRNSHolding(s) in Company
26th Sep 20237:00 amRNSHalf-year Report
25th Sep 20238:25 amRNSHolding(s) in Company
22nd Sep 20237:00 amRNSPurchase Order
20th Sep 20237:00 amRNSAcquisition of MultiQ
11th Sep 202310:33 amRNSReplacement - Investor Presentation via IMC
11th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th Sep 20237:00 amRNSPurchase Orders
7th Aug 20237:00 amRNSHolding(s) in Company
4th Aug 20239:13 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPurchase Order
27th Apr 20231:58 pmRNSResult of AGM
18th Apr 20237:00 amRNSFramework agreement extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.